The market has taken the world’s most-owned stock and, inside two months, compressed it to roughly 22–24x consensus NTM / FY27 earnings — not clearly below the S&P 500, but strikingly close to a market multiple for a company whose revenue just grew 85% year over year — on a be...
Read Article ›The bull/bear standoff here is well worn — an elite compounding franchise trading at roughly 40x earnings against a structural share issuance overhang. That framing is the starting point, not the answer. What tips the balance is the cadence of the underlying metrics: account, ...
Read Article ›The private-credit fear that cut the stock by nearly 40% is aimed at roughly a twentieth of the platform. At ~15x forward adjusted earnings after a brutal drawdown, the confirmation risk over the next several quarters sits with the bears. This is a high-quality compounder on s...
Read Article ›The standing critique of Rocket Lab is simple: elite growth, elite vision, no profits, and a valuation that requires everything to go right. The Iridium acquisition is the most direct possible response to that critique, because Iridium is the thing Rocket Lab has never had—a c...
Read Article ›The market spent two years treating Comcast as a structurally challenged broadband utility with a fading media albatross stapled to it, and priced it accordingly. The separation of NBCUniversal and Sky directly attacks that framing by letting a cash-rich, under-cross-sold conn...
Read Article ›The familiar standoff—elite CF monopoly versus a full multiple and a maturing core—resolves in the buyers' favor once you weight the catalysts by how knowable they are. CF is converting toward ALYFTREK on a long exclusivity runway and funding everything else; that is the demon...
Read Article ›This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
Read Article ›Hawaiian Electric has graduated from tail-risk to execution risk, and that is a genuine improvement in the quality of the investment. The legal cliff is behind it: the global settlement is final, the releases are effective, and the first $479 million installment is paid.
Read Article ›CarMax is deliberately reshaping its earnings mix — trading retail GPU for unit growth while attempting to fund the price competitiveness through cost rather than charity.
Read Article ›The central tension in Dexcom is whether its non-insulin type 2 expansion is a margin-accretive growth wave or a commoditization trap. The resolution is in the sequencing. The catalysts that drive the next several quarters — commercial coverage of all diabetics this summer, G7...
Read Article ›Duolingo is the rare consumer-software franchise that deliberately throttled its own near-term monetization to feed the top of its funnel — and the market has punished it as if the growth engine itself broke. The stock changes hands around **$123**, down roughly three-quarters...
Read Article ›The market is pricing Match Group as a melting ice cube. The leading indicators say the ice has stopped melting — and the cash machine underneath is being badly underrated. Match Group is a portfolio of dating apps wrapped around two assets that matter and a long tail that mos...
Read Article ›Warner Bros Discovery offers a mid-to-high-teens gross return to a $31 cash takeout, backed by a buyer with unusually strong financial credibility–meanwhile the DOJ appears constructive; international approvals are accumulating; and the underlying business—particularly streami...
Read Article ›Intuit shares have been cut roughly in half from their 52-week high, recently trading in the low $300s, while Q3 fiscal 2026 revenue grew 10%, guidance was raised, and the highest-growth engines are compounding above 30%. TurboTax Live — Intuit's AI-plus-expert model — is on t...
Read Article ›Blue Bird is a rare niche manufacturer that has beaten guidance fourteen straight quarters, raised its FY2026 outlook twice, and just completed a deal that materially widens its addressable market. At roughly 17x trailing earnings and ~9x forward Adjusted EBITDA, the stock tra...
Read Article ›L3Harris shares have retreated nearly 20% from their 52-week high near $379, creating a compelling entry into what is shaping up as a multi-year earnings inflection. A record $40.7 billion backlog—which management describes as approximately two times revenue coverage—means the...
Read Article ›Uber's Q1 2026 delivered 25% gross bookings growth to $53.7 billion and a 44% surge in non-GAAP EPS to $0.72, yet the stock trades below $70—roughly 30% below its October 2025 peak. The disconnect between operational execution and stock price reflects GAAP noise from equity in...
Read Article ›Lam Research delivered a record March quarter and guided its June quarter to a stunning $6.6 billion in revenue — roughly 10% above consensus at the time. The business is accelerating across memory, foundry, and services. Yet with shares near $318, up close to 300% in the past...
Read Article ›Boston Scientific shares have been cut roughly in half since mid-2025, driven by a guidance cut, competitive headwinds in electrophysiology, softening WATCHMAN procedure volumes, and a Class I pacemaker recall. Yet the company still posted 9.4% organic growth in Q1 2026, is on...
Read Article ›Invitation Homes trades near $29, roughly 15% below the average sell-side target and at an implied cap rate approaching 7%—well above the low-4% cap rates the company is realizing on home dispositions to end buyers. That gap creates a rare capital-allocation opportunity that m...
Read Article ›